TreeFrog Webinar : Scaling-up iPS-derived cell therapy production while preserving cell quality

First webinar on November 18!

We’re glad to invite you to the first webinar held by TreeFrog Therapeutics on November 18, at 10 am (EST):

Scaling-up iPS-derived cell therapy production
while preserving cell quality

In this webinar, Kevin Alessandri, our CEO & co-founder, will present data showing that:

  • C-Stem enables >100x hPSC expansion per week in bioreactors due to superior cell viability
    C-Stem introduces a new standard for hPSC quality (stemness, pluripotency, genomic integrity)
    C-Stem yields functional 3D hPSC-derived microtissues improving therapeutic efficacyThis overview of the C-Stem technology will be followed by an open discussion.

Hop-Hop-ing to see you there !

 
The TreeFrog Team